Merck (MRK) Tops Q3 EPS by 31c, Revenues Beat; Narrows & Raises FY20 Non-GAAP EPS Guidance Above Consensus, Provides FY20 Revs. Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/11/2026

1. RKLB
2. ACVA
3. SPY
4. CRWV
5. RIOT
6. RPD
7. NVDA
8. HIMS
9. FERG
10. BBIO

Go back to Merck (MRK) Tops Q3 EPS by 31c, Revenues Beat; Narrows & Raises FY20 Non-GAAP EPS Guidance Above Consensus, Provides FY20 Revs. Outlook
Merck & Co. (NYSE: MRK) Delayed: 130.42 -0.5 (0.38%)
Previous Close $130.92    52 Week High $65.46 
Open $129.93    52 Week Low $47.97 
Day High $132.84    P/E 88.72 
Day Low $129.70    EPS $1.47 
Volume 6,343,840